Histone Acetylation and Chemoresistance in Colorectal Cancer: an Opportunity for Effective Personalized TreatmentSamer Alzoubi(Imperial College London)Spiral (Imperial College London)January 1, 201310.25560/11581Cited by 1SaveCiteExport RISWatch citationsRelated PapersSynergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer|Oncotarget|2016|36